Zylox-Tonbridge Executes HK$1.78 Million Share Buyback, Shrinking Free Float by 0.03%

Bulletin Express05-21 19:24

Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 02190) disclosed a share repurchase of 85,000 H shares on 21 May 2026, according to its Next Day Disclosure Return filed the same day.

The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$20.74 to HK$21.24, translating to a volume-weighted average of roughly HK$20.95 and a total consideration of HK$1.78 million.

Post-transaction, issued shares outstanding (excluding treasury stock) fell by 0.0254% to 326.81 million. Treasury shares increased to 9.54 million, while the company’s total issued share count remained unchanged at 336.35 million.

The buyback forms part of a mandate approved on 13 May 2026 that allows the repurchase of up to 32.72 million shares. Cumulative purchases under this mandate now stand at 396,000 shares, representing 0.1182% of the company’s issued capital as at the mandate date.

Under Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing new shares or disposing of treasury shares until 20 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112959826?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112959826","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge Executes HK$1.78 Million Share Buyback, Shrinking Free Float by 0.03%","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 02190) disclosed a share repurchase of 85,000 H shares on 21 May 2026, according to its Next Day Disclosure Return filed the same day.</p>\n<p>The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$20.74 to HK$21.24, translating to a volume-weighted average of roughly HK$20.95 and a total consideration of HK$1.78 million.</p>\n<p>Post-transaction, issued shares outstanding (excluding treasury stock) fell by 0.0254% to 326.81 million. Treasury shares increased to 9.54 million, while the company’s total issued share count remained unchanged at 336.35 million.</p>\n<p>The buyback forms part of a mandate approved on 13 May 2026 that allows the repurchase of up to 32.72 million shares. Cumulative purchases under this mandate now stand at 396,000 shares, representing 0.1182% of the company’s issued capital as at the mandate date.</p>\n<p>Under Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing new shares or disposing of treasury shares until 20 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Executes HK$1.78 Million Share Buyback, Shrinking Free Float by 0.03%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Executes HK$1.78 Million Share Buyback, Shrinking Free Float by 0.03%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 02190) disclosed a share repurchase of 85,000 H shares on 21 May 2026, according to its Next Day Disclosure Return filed the same day.</p>\n<p>The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$20.74 to HK$21.24, translating to a volume-weighted average of roughly HK$20.95 and a total consideration of HK$1.78 million.</p>\n<p>Post-transaction, issued shares outstanding (excluding treasury stock) fell by 0.0254% to 326.81 million. Treasury shares increased to 9.54 million, while the company’s total issued share count remained unchanged at 336.35 million.</p>\n<p>The buyback forms part of a mandate approved on 13 May 2026 that allows the repurchase of up to 32.72 million shares. Cumulative purchases under this mandate now stand at 396,000 shares, representing 0.1182% of the company’s issued capital as at the mandate date.</p>\n<p>Under Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing new shares or disposing of treasury shares until 20 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1112959826","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112959826","pubTimestamp":1779362679,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 02190) disclosed a share repurchase of 85,000 H shares on 21 May 2026, according to its Next Day Disclosure Return filed the same day. The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge执行178万港元股份回购自由流通量缩水0.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 02190) disclosed a share repurchase of 85,000 H shares on 21 May 2026, according to its Next Day Disclosure Return filed the same day.\nThe shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$20.74 to HK$21.24, translating to a volume-weighted average of roughly HK$20.95 and a total consideration of HK$1.78 million.\nPost-transaction, issued shares outstanding (excluding treasury stock) fell by 0.0254% to 326.81 million. Treasury shares increased to 9.54 million, while the company’s total issued share count remained unchanged at 336.35 million.\nThe buyback forms part of a mandate approved on 13 May 2026 that allows the repurchase of up to 32.72 million shares. Cumulative purchases under this mandate now stand at 396,000 shares, representing 0.1182% of the company’s issued capital as at the mandate date.\nUnder Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing new shares or disposing of treasury shares until 20 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112959826","isCrawlerRequest":true}